HOFSETH BIOCARE ASA: årsregnskap 2012 vs 2011
Grew 14215747% on revenue, weaker earnings, cash halved-plus
approved 2013-06-24; registry 2013-08-13; journal 2013 630066
Summary
What changed
Comparing Årsregnskap 2012 with 2011 for HOFSETH BIOCARE ASA. Revenue 183 NOK → 26.02m NOK (+14215747.0%). Net result -19.03m NOK → -73.86m NOK. Equity 120.28m NOK → 48.47m NOK.
On the constructive side: revenue rose. Pressures included: net result weakened; equity eroded; cash fell.
Also worth watching: sharp cash drawdown; paid-in equity reduced; cogs fell. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 183 NOK to 26.02m NOK (+14215747.0% YoY). Calculated
What deteriorated
-
↓
Net result weakened
Net result -19.03m NOK → -73.86m NOK (net margin -10400000.0% → -283.9%). Calculated
-
↓
Equity eroded
Book equity 120.28m NOK → 48.47m NOK (equity ratio 76.1% → 31.2%). Calculated
-
↓
Cash fell
Bank deposits 18.55m NOK → 0 NOK (-100.0% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.66× → 0.30× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (18.55m NOK → 0 NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 120.28m NOK → 58.89m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
COGS fell
COGS / varekostnad 462.0k NOK → 24.6k NOK (-94.7% YoY). Calculated